Publication | Open Access

Synthetic, enzyme kinetic, and protein crystallographic studies of C -β- d -glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase

Enzyme KineticLow Nanomolar InhibitionBiochemistryMedicineGlycobiologyCrystallographic StudiesPharmacologyCarbohydrate-protein InteractionDrug DiscoveryGlycosylation